Fibrinogen Concentrate (FGTW) in Trauma Patients, Presumed to Bleed (FI in TIC)
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
Severe traumatized patients with visible significant bleeding and/or with clinical signs of
internal significant bleeding treated by an emergency doctor of the helicopter service or the
ground team will be enrolled in the study (inclusion- and exclusion criteria: see above). If
a patient meets the inclusion criteria and is recruited for the study, FGTW or placebo
administrated over 5 min/vial:
Body Weight: < 30 kg / 30-60 kg / 60 - 90 kg / > 90 kg
No. of vials: 1 vial (100 ml) / 2 vials (200 ml) / 3 vials (300 ml) / 4 vials (400 ml)
Fibrinogen (if applicable): 1.5 g / 3 g / 4.5 g / 6 g